The Impact of Artificial Intelligence (AI) on the Safety of Patients
The Impact of AI on the Safety of Patients
The Impact of Artificial Intelligence (AI) on the Safety of Patients
As the pace of interest in and development of generative artificial intelligence (genAI) accelerates, there’s a mix of hope and skepticism from health care providers and from patients. While much discussion has focused on operational and clinical applications for genAI, less attention and guidance has focused on how these applications might improve or threaten patient safety, or to inform considerations and practices to ensure the safety and wellbeing of patients and the workforce.
With the generous support of the Gordon and Betty Moore Foundation, the IHI Lucian Leape Institute (LLI) chartered a rapid-cycle innovation wave and expert panel to identify the opportunities and recommendations for genAI through the lens of safety. In this provocative and timely webinar, world renown safety experts will share insights and recommendations from the recent LLI report on patient safety and AI, including an analysis of the benefits, risks, and monitoring and risk mitigation for three clinical genAI applications, including clinical decision support, patient-facing chatbots, and documentation support.
Continuing Education
In support of improving patient care, the Institute for Healthcare Improvement is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
This program is approved to provide 1.5 credits for physicians, nurses, and Certified Professional in Patient Safety (CPPS) recertification.
The Institute for Healthcare Improvement designates this US Physician Internet live course for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity may also be applicable for other professions that accept AMA PRA Category 1 Credits™.
A growing list of countries accept ACCME-accredited education.
As a result of this program, attendees will be able to:
- Identify benefits and risks for 3 key genAI applications from a safety lens.
- Contribute to the development, selection, and implementation of genAI solutions to support safe health care delivery.
Planning Committee
- Robert Watcher, MD, Professor and Chair, Department of Medicine, University of California, San Francisco
- Kaveh Shojania, MD, Professor and Vice Chair (Quality and Innovation), Department of Medicine, University of Toronto
- Britney Pierre, RN, MAS, BSN, Senior Project Manager, IHI
- Patricia McGaffigan, RN, MS, CPPS, Senior Advisor, Patient and Workforce Safety, IHI
Disclosure: None of the planners, presenters, or staff for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.